glp 1 migraine Could GLP-1s prevent migraine? A new study of 22,000 chronic patients suggests...maybe. Over 12 months, GLP-1 users vs topiramate users had: >10% fewer ED visits >14% fewer hospitalizations >48% less likely GLP-1 Meds for Chronic Migraine:

Clinical Rheumatology, 41(12), 3641-3660

The right framing here is that something is plausible via the biological mechanism and has not yet been demonstrated in humans, at a systems level

Compared with those of their unexposed counterparts, the nuclear maturation and spindle configuration of oocytes exposed to in vitro heat stress were significantly impaired

Due to the different levels of enzyme defect with various mutations and the different genes there is wide variability in the severity of the clinical symptoms

Health Canada conditionally approved Wegovy for MASH late last year

It reduces uncertainty about whether patients will switch